Related Experiment Video
Updated: Dec 23, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
2019 Year in Review: Aerosol Therapy
1Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas. berlinskiariel@uams.edu.
Medicinal aerosols offer new COPD and asthma treatments, including combination inhalers and smart devices. However, vaping poses risks, and adherence to inhaled medications remains a challenge.
Area of Science:
- Respiratory Medicine
- Aerosol Science
- Pharmacology
Background:
- Chronic Obstructive Pulmonary Disease (COPD) and asthma management often involve inhaled medications.
- The delivery and efficacy of medicinal aerosols are critical for treatment success.
- Emerging technologies and potential risks associated with aerosolized substances require ongoing review.
Purpose of the Study:
- To review recent advancements in medicinal and toxic aerosols.
- To highlight new therapeutic strategies for respiratory diseases.
- To discuss safety concerns and technological innovations in aerosol delivery.
Main Methods:
- Literature review of relevant publications on medicinal and toxic aerosols.
- Analysis of clinical trial outcomes and observational studies.
- Synthesis of data on drug efficacy, safety, and device technology.
Main Results:
- Combination inhalers (aclidinium bromide/formoterol fumarate) show superiority in COPD treatment.
- As-needed budesonide-formoterol is effective for mild-to-moderate asthma.
- Electronic nicotine delivery systems are linked to increased asthma exacerbations in children.
- Smart inhalers and inhaled hypertonic saline show promise for specific respiratory conditions.
- Inhaled liposomal amikacin improves sputum culture negativity in Mycobacterium avium complex disease.
- Surgical masks reduce bacterial aerosol burden in cystic fibrosis patients.
- E-cigarette or vaping-associated lung injury (EVALI) caused significant casualties in 2019.
Conclusions:
- Combination therapies and novel delivery systems are advancing respiratory care.
- Adherence to inhaled medications requires attention, particularly in adolescents.
- Risks associated with vaping necessitate public health awareness.
- Further research is needed to optimize aerosol-based therapies and mitigate risks.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

